| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/15/2008 | WO2008057313A2 Methods of using e2f2 for the treatment of hypertension |
| 05/15/2008 | WO2008057298A2 Lipidized interferon and uses thereof |
| 05/15/2008 | WO2008057209A1 Hcv ns3 protease inhibitors |
| 05/15/2008 | WO2008057208A2 Hcv ns3 protease inhibitors |
| 05/15/2008 | WO2008057162A2 Native (telopeptide) placental collagen compositions |
| 05/15/2008 | WO2008056726A1 Glp-1 derivative and use thereof |
| 05/15/2008 | WO2008056155A1 Selective glucagon-like-peptide-2 (glp-2) analogues |
| 05/15/2008 | WO2008056114A1 Arginase in pregnancy |
| 05/15/2008 | WO2008055801A2 Antidiabetogenic calcium-peptide composition |
| 05/15/2008 | WO2008055651A1 Improved biological effects of compositions comprising rosmarinic acid |
| 05/15/2008 | WO2008055626A1 Protein-containing substance with increased thermal stability |
| 05/15/2008 | WO2008055445A1 Method and composition for increasing insulin sensitivity |
| 05/15/2008 | WO2008055314A1 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 05/15/2008 | WO2008055310A1 Process for the preparation of angiogenin |
| 05/15/2008 | WO2008036258A3 Collyrium for dry eye |
| 05/15/2008 | WO2008035370A3 Compositions for prevention and treatment of mastitis and metritis |
| 05/15/2008 | WO2008034866A3 Dbait and uses thereof |
| 05/15/2008 | WO2008031820A3 Combinations of class-i specific histone deacetylase inhibitors with proteasome inhibitors |
| 05/15/2008 | WO2008028928A8 Novel combination of agents for the treatment of hiv-associated adipose redistribution syndrome (hars) |
| 05/15/2008 | WO2008014603A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/15/2008 | WO2008012542A3 Polysaccharide derivatives of erythropoietin |
| 05/15/2008 | WO2008005527A3 Glucagon-like peptides and uses thereof |
| 05/15/2008 | WO2007144768A3 Use of peptidic vasopressin receptor agonists |
| 05/15/2008 | WO2007135563A3 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/15/2008 | WO2007126792A3 Use of ghrelin splice variant for treating high cholesterol levels or high plasma glucose levels and releated diseases |
| 05/15/2008 | WO2007084765A3 Injectable combination therapy for eye disorders |
| 05/15/2008 | WO2007082742A8 Isolated organ perfusion combination therapy of cancer |
| 05/15/2008 | WO2007031727A3 System for delivering neuronal calcium sensor - 1 (ncs - 1) |
| 05/15/2008 | WO2005102378A3 Modular furniture system |
| 05/15/2008 | US20080114458 Intervertebral disc treatment devices and methods |
| 05/15/2008 | US20080114155 Modified Human Interferon Polypeptides and Their Uses |
| 05/15/2008 | US20080114154 Protease resistance |
| 05/15/2008 | US20080114069 Methods of inducing terminal differentiation |
| 05/15/2008 | US20080114025 Inhibiting a variety of pain, inflammation, spasm and restenosis processes resulting from cardiovascular or general vascular therapeutic and diagnostic procedures; use of ADP receptor antagonist and a thromboxane A2 receptor antagonist |
| 05/15/2008 | US20080114011 Enhancement of Effectiveness of 5-Fluorouracil in Treatment of Tumor Metastases and Cancer |
| 05/15/2008 | US20080113960 Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor |
| 05/15/2008 | US20080113933 polynucleotide molecules that encode the Chlamydia polypeptides designated 60 kDa cysteine-rich membrane proteine which can be used to prevent, treat, and diagnose Chlamydia infection |
| 05/15/2008 | US20080113928 Modified Cea/B7 Vector |
| 05/15/2008 | US20080113919 prenylation enzyme inhibitors such as 5,9,13-trimethyl-2-nitrotetradeca-2,8,12-triene, used as anticarcinogenic or antitumor agents |
| 05/15/2008 | US20080113918 Oral, intravenous, skin or nasal dosage form of agonist polypeptide containing amino acid sequence FCIGRL with less than 100 amino acid residues in length; antiinflmmatory agents |
| 05/15/2008 | US20080113917 A fusion protein expressed in a protease resistant scaffold and protease inhibitor is selected from the group consisting of Bowman-Birk Inhibitor, soybean trypsin inhibitor, and Eglin chymotrypsin inhibitor; capable of modulating human hair growth |
| 05/15/2008 | US20080113916 Povidone-Containing Carriers for Polypeptide Growth Factors |
| 05/15/2008 | US20080113915 diagnosing an individual with anxiety associated with reduced expression of a SAPAP3 gene product as compared to a wild type non-human mammal of the same species that does not contain a disruption in one or both alleles of its endogenous SAPAP3 gene; drug screeing; quantitative analysis; |
| 05/15/2008 | US20080113914 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid |
| 05/15/2008 | US20080113913 Formulations of Human Growth Hormone Comprising a Non-Naturally Encoded Amino Acid |
| 05/15/2008 | US20080113912 hGH polypeptide comprises one or more post-translational modifications; is linked to a linker, polymer, or biologically active molecule; linked to a bifunctional polymer, bifunctional linker, or at least one additional hGH polypeptide |
| 05/15/2008 | US20080113911 administer effective dose of human Egfl7 polypeptide agonist; intravenous, intra-arterial, intra-pericardial, systemic, subcutaneous, intramuscular, by inhalation, topical, transdermal; tumor growth, atherosclerosis, diabetic retinopathy, age-related maculopathy, and retrolental fibroplasia |
| 05/15/2008 | US20080113910 Polypeptides or peptides with no risk for viral infection, pathogens, prions; not evoke immune response; gelatine consists of native human collagen sequences; coating on scaffolds for tissue engineering, implant, transplant materials; component of drug delivery systems for inhibition of cancer metastasis |
| 05/15/2008 | US20080113909 Compositions and Methods for Treating Stat-6 Associated Diseases or Conditions |
| 05/15/2008 | US20080113908 Use of CRF receptor agonists for the treatment or Prophylaxis of diseases, for example Neurodegenerative diseases |
| 05/15/2008 | US20080113907 Uses Of Galectin-2 |
| 05/15/2008 | US20080113906 Sushi Peptide Multimer |
| 05/15/2008 | US20080113905 Biologically active peptide with extended half-life and a slower clearance compared to unPEGylated peptide; PEGylated GLP-1 compounds treat diabetes, obesity, irritable bowel syndrome |
| 05/15/2008 | US20080113904 Treatment of Neurological Conditions Using Complement C5a Receptor Modulators |
| 05/15/2008 | US20080113903 Prevent mammals tissue injuries |
| 05/15/2008 | US20080113902 Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 05/15/2008 | US20080113901 Administering agent that induces nitrosylation of hemoglobin andhyperoxic gas |
| 05/15/2008 | US20080113900 Nutraceutical; reduce serum homocysteine levels; protects cells from damage and death when exposed to oxidative stress conditions; human food supplements, multivitamin preparations, breakfast foods, infant formulas, complete diet and weight-loss formulas and bars |
| 05/15/2008 | US20080113899 Iron Supplement and Utilization of the Same |
| 05/15/2008 | US20080113898 Methods for detecting and inhibiting angiogenesis using peptides |
| 05/15/2008 | US20080113896 Nutraceutical, medicament; peptides isoleucine-proline-proline and valine-proline-proline from casein; dietary supplement or a personal care application; topical lotion, gel; emulsion, food, beverage, feed or pet food ingredient |
| 05/15/2008 | US20080113436 Mixture comprising mannitol for suspending animal or human cells and for dissolving biologically active molecules in order to introduce molecules into cells using electric current |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113412 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 05/15/2008 | US20080113411 Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses |
| 05/15/2008 | US20080113399 Identifying compounds for use in treatment and prevention bone disorders |
| 05/15/2008 | US20080113343 Method of Inhibiting Prostate Cancer Cell Proliferation |
| 05/15/2008 | US20080113340 Diagnosis and treatment of cervical cancer |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080113017 Sterol derivatives, liposomes comprising sterol derivatives and method of loading liposomes with active substances |
| 05/15/2008 | US20080113015 drug delivery devices comprising capsules containing drugs distributed within an aqueous phase in the interior of the capsule |
| 05/15/2008 | US20080113011 drug mixture comprising interferons, gelatin, phosphatidylcholine didecanoyl, methyl-beta-cyclodextrin, ethylenediamine tetraacetic acid and benzalkonium chloride, having improved pharmacokinetics, used for treating autoimmune and viral diseases, by administering to mucous membranes |
| 05/15/2008 | US20080113008 Absorbent fabric implant |
| 05/15/2008 | US20080113007 Amniotic membrane having fibrinogen and thrombin attached on a surface; transplantation material for reconstructing the ocular surface or the skin; transparency and strength; excellent in biological affinity, low immunogenicity; no suturing necessary |
| 05/15/2008 | US20080112994 Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
| 05/15/2008 | US20080112990 Cosmetic Compositions |
| 05/15/2008 | US20080112981 Treatment of fine wrinkles with Clostridia Neurotoxins |
| 05/15/2008 | US20080112958 Using epidermal growth factor receptor antagonist as therapeutic tool in treatment of cell proliferative disorders |
| 05/15/2008 | US20080112955 Method and composition for preventing pain in sickle cell patients |
| 05/15/2008 | US20080112947 I kappa b kinase complex as a target for the treatment of huntington's disease |
| 05/15/2008 | US20080112946 Catalytically active recombinant memapsin and methods of use thereof |
| 05/15/2008 | US20080112945 Mixture comprising dexamethasone, vitamin B, metronidazole, berberine, etamsylate, gentamicin, chymotrypsin, methylene blue trihydrate and sodium bicarbonate for improving effectiveness of local anesthetics |
| 05/15/2008 | US20080112944 Compositions and methods for the treatment of autism |
| 05/15/2008 | US20080112943 Biosynthetic Polypeptide Fusion Inhibitors |
| 05/15/2008 | US20080112942 Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption |
| 05/15/2008 | US20080112930 Stent coated with sarcoplasmic reticulum calcium ATPase (SERCA) nucleotide sequences for use in treatment and prevention of vascular constriction |
| 05/15/2008 | US20080112926 Preparing chimeric polypeptide comprising glycosaminoglycan-binding proteins (GAG) for use in prevention and treatment of skin, nervous system and inflammatory disorders |
| 05/15/2008 | US20080112925 Qs-21 and il-12 as an adjuvant combination |
| 05/15/2008 | US20080112924 Dendritic Cells Loaded with Heat Shocked Melanoma Cell Bodies |
| 05/15/2008 | US20080112919 Tnp-470 polymer conjugates and use thereof |
| 05/15/2008 | US20080112917 Sphingolipids' Polyalkylamines Conjugates |
| 05/15/2008 | US20080112915 Skin disorders; metabolic disorders; gene therapy; biocompatability |
| 05/15/2008 | US20080112900 Chewable Antiplaque Confectionery Dental Composition |
| 05/15/2008 | US20080112896 Microparticles obtained by spray-freeze-drying a solution or dispersion of a water-soluble matrix such as hyaluronic acid and drug; lightweight, porous to deposit deeply in lungs; mucoadhesion; time-release agents |
| 05/15/2008 | DE102006053375A1 Verfahren zur Mischung von Pulvern A method for mixing of powders |
| 05/15/2008 | DE102006053071A1 Protein-enthaltender Stoff mit erhöhter Temperaturstabilität Protein-containing material with high thermal stability |
| 05/15/2008 | DE102006052755A1 New peptide derivatives and peptidomimetics are transglutaminase inhibitors useful for the treatment or prophylaxis of e.g. celiac disease, fibrosis, thrombosis, neurodegenerative disorders, Huntington's chorea and Parkinson disease |
| 05/15/2008 | DE102005016234B4 Verfahren zur Einschleusung von exogenem Antigen in den MHC I-Präsentationsweg von Zellen Method for the introduction of exogenous antigen into the MHC class I presentation pathway of cells |
| 05/15/2008 | CA2702645A1 Process for the preparation of angiogenin |
| 05/15/2008 | CA2669806A1 Selective glucagon-like-peptide-2 (glp-2) analogues |